You have 9 free searches left this month | for more free features.

Frontline therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

A Study of Rituximab in Frontline Therapy for Glomerulonephritis

Recruiting
  • Glomerulonephritis
    • Shanghai, China
    • +4 more
    Feb 27, 2023

    Frontline of ASCT in High-risk DLBCL

    Recruiting
    • Diffuse Large B Cell Lymphoma
      • Beijing, Beijing, China
        Peking University People's Hospital
      Apr 26, 2023

      Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

      Not yet recruiting
      • Ovarian Cancer
      • Houston, Texas
        MD Anderson Cancer Center
      Oct 9, 2023

      Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • (no location specified)
      Mar 1, 2023

      Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)

      Not yet recruiting
      • Secondary Acute Myeloid Leukemia
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Mar 22, 2023

      Leukemia Trial in Boston, Houston (Venetoclax, Standard Chemotherapy)

      Recruiting
      • Leukemia
      • Chicago, Illinois
      • +2 more
      Oct 3, 2022

      Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • ADI-PEG 20
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 14, 2022

      Safety Issues, Efficacy, Self Trial in Monterrey (low dose nivolumab in combination with AVD)

      Recruiting
      • Safety Issues
      • Efficacy, Self
      • low dose nivolumab in combination with AVD
      • Monterrey, Nuevo Leon, Mexico
        Hospital Universitario Dr Jose Eleuterio Gonzalez
      Mar 6, 2023

      Peripheral T Cell Lymphoma Trial in Zhengzhou (Golidocitinib, CHOP Regimen)

      Not yet recruiting
      • Peripheral T Cell Lymphoma
      • Zhengzhou, Henan, China
        Henan Cancer Hospital
      Jul 18, 2023

      Post-transplant Lymphoproliferative Disorder Trial in Saint Louis (Polatuzumab vedotin, Rituximab, CHP)

      Not yet recruiting
      • Post-transplant Lymphoproliferative Disorder
      • Polatuzumab vedotin
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Sep 9, 2023

      Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy

      Recruiting
      • Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer
      • Banqiao, New Taipei, Taiwan
        Department of Obstetrics and Gynecology, Far Eastern Memorial Ho
      Jan 1, 2023

      Classical Hodgkin Lymphoma, Hodgkin Disease Refractory, Hodgkin Disease Recurrent Trial in United States (Nivolumab, Autologous

      Recruiting
      • Classical Hodgkin Lymphoma
      • +2 more
      • Duarte, California
      • +4 more
      Jun 27, 2022

      Insomnia, Post Traumatic Stress Disorder, Anxiety Disorders Trial in Toronto (Digital Cognitive Behavioral Therapy for Insomnia

      Not yet recruiting
      • Insomnia
      • +3 more
      • Digital Cognitive Behavioral Therapy for Insomnia (dCBTi)
      • Toronto, Ontario, Canada
        Toronto Western Hospital
      Apr 13, 2023

      Multiple Myeloma Trial in Shanghai (GC012F injection)

      Recruiting
      • Multiple Myeloma
      • GC012F injection
      • Shanghai, Shanghai, China
        Shanghai Changzheng Hospital
      Aug 1, 2022

      Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)

      Active, not recruiting
      • Pancreatic Adenocarcinoma
      • Fairway, Kansas
        Kansas University Cancer center
      Nov 2, 2022

      Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)

      Completed
      • Multiple Myeloma and Plasma Cell Neoplasm
      • Buffalo, New York
        Roswell Park Cancer Institute
      Sep 30, 2022

      Metastatic Triple-Negative Breast Carcinoma Trial (PVX-410)

      Not yet recruiting
      • Metastatic Triple-Negative Breast Carcinoma
      • (no location specified)
      Apr 18, 2022

      Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Stage I Chronic Lymphocytic Leukemia
      • +3 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Mar 24, 2022

      Primary CNS Lymphoma Trial in Beijing (Orelabrutinib, Pomalidomide, Rituximab)

      Recruiting
      • Primary Central Nervous System Lymphoma
      • Beijing, Beijing, China
      • +2 more
      May 19, 2022

      Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Birmingham, Alabama
      • +8 more
      Jan 24, 2023

      High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

      Not yet recruiting
      • High-Risk de Novo Multiple Myeloma
      • Badalona, Spain
      • +9 more
      Apr 27, 2023

      Advanced Soft Tissue Sarcoma, Advanced Epithelioid Sarcoma Trial in Worldwide (Tazemetostat, Placebo, Doxorubicin HCl)

      Recruiting
      • Advanced Soft Tissue Sarcoma
      • Advanced Epithelioid Sarcoma
      • Duarte, California
      • +20 more
      Jan 31, 2022

      AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma Trial in Duarte

      Active, not recruiting
      • AIDS-related Non-Hodgkin Lymphoma
      • +3 more
      • Duarte, California
        City of Hope Medical Center
      Feb 17, 2022

      Hodgkin Lymphoma Trial in Canada, United States (doxorubicin, Bleomycin, vinblastine)

      Recruiting
      • Hodgkin Lymphoma
      • Detroit, Michigan
      • +9 more
      Feb 16, 2022

      Insomnia Trial in Jakarta Pusat (Press needles, Filiform Needles)

      Completed
      • Insomnia
      • Press needles
      • Filiform Needles
      • Jakarta Pusat, DKI Jakarta, Indonesia
        Cipto Mangunkusumo Hospital
      Aug 17, 2022